Last reviewed · How we verify
Stromal vascular fraction transplantation
Stromal vascular fraction transplantation is a Biologic drug developed by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University. It is currently in Phase 1 development.
At a glance
| Generic name | Stromal vascular fraction transplantation |
|---|---|
| Sponsor | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee (PHASE1)
- The Effect of Stromal Vascular Fraction Transplantation on the Regeneration of Expanded Skin (NA)
- Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency (NA)
- Skin Dermal Regeneration After Stromal Vascular Fraction Transplantation (NA)
- SVF Combined With Functional Self-assembling Peptide Nanofiber Hydrogels in the Treatment of Spinal Cord Injury (NA)
- Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson (PHASE1, PHASE2)
- Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease (PHASE1, PHASE2)
- Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Stromal vascular fraction transplantation CI brief — competitive landscape report
- Stromal vascular fraction transplantation updates RSS · CI watch RSS
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University portfolio CI
Frequently asked questions about Stromal vascular fraction transplantation
What is Stromal vascular fraction transplantation?
Stromal vascular fraction transplantation is a Biologic drug developed by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University.
Who makes Stromal vascular fraction transplantation?
Stromal vascular fraction transplantation is developed by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (see full Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University pipeline at /company/shanghai-ninth-people-s-hospital-affiliated-to-shanghai-jiao-tong-university).
What development phase is Stromal vascular fraction transplantation in?
Stromal vascular fraction transplantation is in Phase 1.